|
| Exchange Received Time 04/08/2017 15:42:54 Exchange Disseminated Time 04/08/2017 15:42:59 Time Taken 00:00:05 | This is to inform you that the Board of Directors of the Company at its meeting held today, inter-alia, considered and approved the following:
1.Un-Audited Financial Results and Limited Review Report of the Company for the quarter ended on June 30, 2017;
2.Recommendation for appointment of Mr. Harpal Singh, Director of the Company, liable to retire by rotation at the ensuing Annual General Meeting, subject to the approval of the shareholders;
3.In-principle approval to enable the Company for raising of funds upto Rs. 5000 crore, subject to the approval of the shareholders and other regulatory approvals;
4. Convening of 21st Annual General Meeting of the Company on Tuesday, September 26, 2017 at 12.00 Noon at National Institute of Pharmaceutical Education and Research Mohali, Sector 67, SAS Nagar, Mohali - Punjab-160062; and
5.Cut-off date for reckoning members eligible for voting shall be September 19, 2017.The detailed outcome is attached. |
|
|